Radiotherapy for breast cancer has evolved over the past few years. Initially, radiotherapy for patients with early breast cancer was performed by delivering a total dose of 50 Gy, i.e., 25 fractions of 2.0 Gy. Gradually, different treatment schedules were developed offering shorter schedules with lower total doses. According to the current ESTRO-ACROP recommendations, the standard of care is the 15-fraction START schedule which can be used regardless of the area to be irradiated. But the occurrence of COVID-19 pandemic has prompted Ste-Elisabeth hospital to treat all nodepositive breast cancer patients over 65 years of age with a shorter 5-fraction FAST schedule, i.e., one fraction per week for five weeks, based on French retrospective data and long experience. However, currently, FAST-Forward ultrahypofractionation with 5-fraction radiotherapy (one fraction per day) is still not recommended in the axillary area for safety reasons and the FAST schedule is not mentioned.
| la date de réponse | 17 janv. 2023 |
|---|
| langue originale | Anglais |
|---|
| L'institution diplômante | |
|---|
| Superviseur | Vincent M. Remouchamps (Promoteur) & Anne-Emmanuella Yeo (Copromoteur) |
|---|
Loco-Regional Adjuvant Radiotherapy in Breast Cancer: Retrospective Analysis of the Toxicity and Impact of the COVID-19 Pandemic
Stokart, J. (Auteur). 17 janv. 2023
Student thesis: Master types › Master en sciences biomédicales à finalité spécialisée en recherche clinique